Agomelatine

Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression（SMART-I)

A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression

A Double-blind, Placebo-controlled Study of Antidepressant Augmentation With Agomelatine

A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia

Prophylactic Effects of Agomelatine for Poststroke Depression

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)

Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients

Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)

Pharmacovigilance in Gerontopsychiatric Patients

Agomelatine in Depressed Patients With Fibromyalgia

A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication

Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)

The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder